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Corpus callosumTheMET tyrosine kinase has been identiﬁed as a susceptibility gene in patients with autism spectrum disorders.
MET is expressed in the forebrain during prenatal and postnatal development. After birth, MET participates in
dendritic outgrowth and circuit formation. Alterations in neuronal development, particularly in the cerebral
cortex, may contribute to the pathology of developmental disorders, including autism. Patients with autism
can exhibit abnormal cortical volumes and head circumferences.We tested thehypothesis that impairedMet sig-
naling during development alters forebrain structure. We have utilized a conditional mutant mouse line which
expresses a kinase-dead Met restricted to the cerebral cortex and hippocampal structures. In these mice, we
have used magnetic resonance imaging (MRI) to analyze the structure of the cerebral cortex and related struc-
tures across postnatal development.We found that the rostral cortex, caudal hippocampus, dorsal striatum, thal-
amus, and corpus callosum were all larger in adult, but not juvenile, mutant mice relative to control mice. The
speciﬁcity of the changes suggests that aberrant expansion of the forebrain is consistent with continued axonal
and dendritic growth, potentially leading to improper circuit formation and maintenance.
© 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.
.Introduction
Autism spectrum disorder (ASD) is characterized by communication
and social interaction impairments, as well as repetitive behaviors and
narrow interests (APA, 2000). Autisms are highly heritable (Folstein and
Rosen-Sheidley, 2001; Hallmayer et al., 2011). Many single gene muta-
tions, such as those underlying Fragile X (FMR1), Rett (MECP2) and tuber-
ous sclerosis (TSC1 and TSC2) syndromes, lead to autistic behaviors in a
signiﬁcant fraction of patients (Bailey et al., 2001; Gutknecht, 2001;
Lewis et al., in press; Percy, 2011; Smalley et al., 1992). However, no single
gene has been identiﬁed for idiopathic autism, but multiple susceptibility
factors are being identiﬁed (Anney et al., in press; Griswold et al., 2012).
ASDs show considerable variability in both symptoms and pathology,airs; CC, corpus callosum; ctx,
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enhancement; SEM, standard
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well).
nc. Open access under CC BY-NC-ND land it is possible that different genetic susceptibilities in combination
with environmental insults may underlie the observed variations
(Abrahams and Geschwind, 2010; Hallmayer et al., 2011; Stoltenberg et
al., 2010; Tassone et al., 2011; Williams and Casanova, 2011).
Studies have shown alterations in brain size in ASD (Amaral et al.,
2008; Redcay and Courchesne, 2005; Stigler et al., 2011). Regions
such as the frontal and temporal cortex (Carper et al., 2002; Hazlett
et al., 2006), hippocampus (Schumann et al., 2004), and caudate
(Hollander et al., 2005; Sears et al., 1999) have been shown to be ex-
panded in autism, while the thalamus is reduced (Tsatsanis et al.,
2003). Several studies have also found increases in white matter vol-
ume in autistic patients, particularly in radiate white matter (Freitag
et al., 2009; Herbert et al., 2003; Herbert et al., 2004). Notably, the al-
terations in brain size in ASD appear to be age-dependent, with in-
creases in brain size being reported more consistently in very young
patients, leveling off during childhood and adolescence, and possible
increased volume in some brain structures into adulthood (Amaral et
al., 2008; Aylward et al., 2002; Carper et al., 2002; Courchesne et al.,
2011; Duerden et al., 2012; Hazlett et al., 2011; Piven et al., 1995;
Redcay and Courchesne, 2005).
Met (also known as c-Met) is a receptor tyrosine kinasewhich binds
the high-afﬁnity ligand hepatocyte growth factor (HGF) (Naldini et al.,
1991). Recently, decreased Met function has been found to increase
the risk of developing autism spectrum disorders (Campbell et al.,
2006; Sousa et al., 2009; Thanseem et al., 2010). Met is crucial during
normal development (Birchmeier and Gherardi, 1998), and mediatesicense
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processes (Gutierrez et al., 2004; Maina et al., 1997; Powell et al.,
2001; Powell et al., 2003b). Importantly, both Met and its ligand, HGF,
are expressed in the brain during development (Achim et al., 1997;
Bae et al., 2010; Honda et al., 1995; Judson et al., 2009; Martins et al.,
2007; Martins and Powell, 2011; Powell et al., 2001). Met transcript
expression is prominent in the cerebral cortex, hippocampus, and
amygdala, whileMet protein can also be detected inwhitematter tracts
such as the corpus callosum(Judson et al., 2009). Changes inMet signal-
ing during development could therefore affect neuronal number aswell
as the complexity of the neuropil (Bae et al., 2010; Martins et al., 2007;
Martins and Powell, 2011; Powell et al., 2003b). Indeed, inactivation of
Met in the cerebral cortex has been shown to alter the strength of local
excitatory connections between layers 2/3 and 5 (Qiu et al., 2011).
Changes in Met function during development may therefore alter the
structure or connectivity of cortical and subcortical structures, and ulti-
mately impact their function.
Despite progress in the understanding of the neurobiology of au-
tism, and the role Met plays in neurodevelopment, it remains unclear
how disruption of HGF–Met signaling could contribute to defects like
those seen in ASD. Anatomical studies in humans likely reﬂect the ef-
fects of multiple different changes at the genetic level, as reﬂected in
the considerable heterogeneity observed between studies. Further-
more, human studies have generally not attempted to correlate
changes in brain structure to speciﬁc genetic variations. To this end,
we have utilized a mouse line in which Met is inactivated speciﬁcally
in the cerebral cortex and hippocampus using a Cre-loxP recombination
strategy. This allows us to examine the effects of loss of Met function on
a constant genetic background. Unlike global Met null mutants (Bladt et
al., 1995),Met–Emx1mice live to adulthood (Judson et al., 2009), allowing
us to examine brain structure during the postnatal and adult periods.
Here we report long-term speciﬁc structural changes after altering Met
signaling in the embryonic mouse dorsal telencephalon.
Material and methods
Animals
Emx1-Cre (K. Jones, University of Colorado) and Met-fx
(S. Thorgeirsson, National Cancer Institute, NIH) mice were generous
gifts from collaborators and backcrossed onto the C57BL/6J strain
obtained from the Jackson Laboratory (Bar Harbor, ME). Mice used in
these experiments were littermates resulting from matings between
non-sibling heterozygotes (fx/+:Cre). All mice were genotyped via
PCR using the following primer sets: Met-fx primers 5′-TTA GGC AAT
GAG GTG TCC CAC-3′ and 5′-CCA GGT GGC TTC AAA TTC TAA GG- 3′
(380 bp for the ﬂoxed allele and 300 bp for wildtype); Emx1-Cre
primers 5′-CAC CCT GTT ACG TAT AGC CG-3′ and 5′-GAG TCA TCC TTA
GCG CCG TA-3′ (320 bp). For this study control mice were wildtype
(+/+) and mutant mice were homozygous for the Met mutation,
Met(fx/fx)/Emx1(Cre),written asMet–Emx1.
MRI imaging
At postnatal day 30 (P30) or after postnatal day 90 (adult), mice
were transcardially perfused with 0.9% saline followed by 4% buffered
paraformaldehyde. The ﬁxed brains were subsequently scanned via
MRI. All experiments were performed on a Bruker Biospec 7.0 T
30 cm horizontal bore scanner equipped with a 12 cm inner diameter
gradient and a gradient strength of 400 mT/musing Paravision 5.0 soft-
ware. A Bruker 1H surface coil array was used as the receiver and
a Bruker 72 mm linear-volume coil as the transmitter. Three-
dimensional (3D) T2-weighted images were acquired using a rapid ac-
quisition with relaxation enhancement (RARE) sequence (TEeff/TR=
60/1500 ms, rare factor 16 , number of averages 3) with a ﬁeld of
view of 25.6×25.6×18 mm3 for a 100 μm3 spatial resolution. Thetotal acquisition time for each sample was approximately 3 h and
36 min.
Area and volume estimation
Post-imaging analysis for volume and area was performed using
NIH ImageJ software (version 1.43u). Fig. 1 shows the boundaries of
the regions of interest that were measured in the coronal plane
(Fig. 1A–C), as well as in the mid-sagittal plane (Fig. 1D). Measure-
ments of the whole brain included all structures from the rostral
extent of the cerebral cortex (bregma ~4.0 mm, (Paxinos and
Franklin, 2001)) to the caudal brainstem-spinal cord juncture
(bregma ~8.5 mm). The area of the cerebral cortex was measured
from pia to white matter, with boundaries deﬁned rostrally by the
emergence of the olfactory bulb, caudally by the plane in which
the deep white matter (dorsal hippocampal commissure) was no
longer visible, and ventrally by the rhinal sulcus, end of the CC, or
level of the anterior commissure (from caudal to rostral). Measure-
ments of the hippocampus include both the upper and lower leaves.
The hippocampus is bordered dorsally and laterally by the corpus
callosum (CC), lateral ventricles, or ﬁmbria, and ventrally and medi-
ally by the thalamus, third ventricle, alveus hippocampus, brachium
superior colliculus, or optic tract.
Measurements of the striatum include the caudate and putamen.
The boundaries of the striatum were deﬁned medially by the lateral
ventricles and internal capsule, laterally and dorsally by the external
capsule, and ventrally by the anterior commissure. Measurements of
the thalamus include both thalamic and hypothalamic nuclei. The
boundaries of this region were deﬁned laterally by the internal capsule
and cerebral peduncle, dorsally by the hippocampus, and ventrally by
the ventral surface of the brain. Measurements of the thalamus did
not include the third ventricle or posterior commissure.
Data analysis
Four brains were imaged for each of the P30 control, P30Met–Emx1,
adult control, and Met–Emx1 groups. The images analyzed represent
100 μm thick sections, with a voxel size of 0.1×0.1×0.1 mm. With
the exception of measurements of the whole brain, area measure-
ments were taken separately for each hemisphere. The distributions
of cross-sectional areas across different rostrocaudal levels were
compared between control and Met–Emx1 mice at each age with
Kolmogorov–Smirnov (K–S). For volume comparisons, measurements
were made for the left and right hemispheres for each structure. The
overall volume of each structure was compared using a three-way
ANOVA in SigmaPlot12 (Systat Software, San Jose, CA) followed by a
Bonferroni t-test as appropriate. Cortical thickness and surface area
were compared between adult control and Met–Emx1 mice using a
Student's t test.
Results
Alterations in gray-matter structures in adult, but not juvenile,
Met–Emx1 mice
Met was inactivated in the cerebral cortex and hippocampus by the
selective removal of the intracellular signaling domain (encoded by
exon 16) (Huh et al., 2004), using a Cre-loxP recombination strategy
with the Emx1-Cre mouse driver (Gorski et al., 2002). The Met–Emx1
mice were viable in agreement with the previous reports (Judson et
al., 2009; Judson et al., 2010; Qiu et al., 2011). Initial histological exam-
ination suggested altered cortical thickness and prompted anMRI struc-
tural study of uncut ﬁxed brains.
Whole brain — total brain weight was measured for all groups
(P30 control=0.444±0.01 g, P30 Met–Emx1=0.421±0.02 g, adult
control=0.411±0.07, adult Met–Emx1=0.514±0.06 g).
Fig. 1. Schematics representing the areas included inmeasurements of the cerebral cortex, hippocampus, striatum, thalamus and corpus callosum in coronal sections at bregma=+0.94 mm
(A) bregma=−1.36 mm (B) and bregma=−2.56 mm (C) and in a parasagittal section (D). Bar=2 mm (A–C) and 2 mm (D).
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2.548, p=0.136) or age (F(1,15)=1.395, p=0.260). A genotype×age
interaction was found (F(1,15)=6.082, p=0.030), with signiﬁcant dif-
ferences between P30 and adult Met–Emx1 brains (p=0.024) and be-
tween adult control and adult Met–Emx1 brains (p=0.014). These
data suggest thatwhile neither theMet allele nor age individually alters
total brain weight, the combination contributes to an overall increased
brain size.
The cross-sectional area of the entire brain was estimated. Cross
sectional area of the whole brain was similar for control and Met–
Emx1 mice at P30 (Fig. 2A, D=0.0527, p=0.514, K–S test). The
cross-sectional area was increased in adult Met–Emx1 animals com-
pared to control (Fig. 2B, D=0.2345, pb0.001, K–S test). No signiﬁ-
cant effects of either genotype (F(1,15)=3.031, p=0.107) or age
(F(1,15)=2.395, p=0.148, two-way ANOVA) were found on total
brain volume. The interaction of genotype×age was signiﬁcant at
the pb0.1 level (F(1,15)=4.418, p=0.057). In control mice, whole
brain volume did not change from P30 to adult, from 406.1±
13.4 mm3 to 391.5±19.3 mm3 (p=0.702, Bonferroni t test). By con-
trast, a signiﬁcant increase in volume was observed in the Met–Emx1
mice, from 396.6±15.3 mm3 at P30 to 492.7±44.6 mm3 in adults
(p=0.024, Bonferroni t test). Similar to the total brain weight, the
combination of the Met allele and age lead to increased brain volume
in the adult Met–Emx1 mice.Fig. 2. Loss of Met function alters whole-brain cross-sectional area. The average cross
sectional area of the brain is plotted versus estimated bregma level for P30 (A) and
adult (B) animals. The cross sectional area of the whole brain is similar between P30
control and Met–Emx1 mice (D=0.0527, p=0.514, K–S test). However, the brains of
adult Met–Emx1 mice are larger than control brains (D=0.2345, pb0.001, K–S test).
Data represent n=4 brains per genotype and age, points represent the mean areas
with the error bars signifying the SEM.Cerebral cortex
We initially focused on the cerebral cortex and hippocampus, the
areas which were targeted by Emx1-Cre expression (Gorski et al.,
2003). The brains from control juvenile (P30) mice looked similar to
Met–Emx1 mice, whereas the cerebral cortex in the adult Met–Emx1
mouse appeared slightly larger overall (Fig. 3A–H). The distributions
of areas were not signiﬁcantly different for the juvenile control and
Met–Emx1 mice (Fig. 3I, D=0.1076, p=0.067, K–S test). Although
in frontal regions (bregma levels>2.5 mm), the areas in the Met–
Emx1 mice were larger on average than in control mice. In the adult
mice, the distributions of cerebral cortical areas were signiﬁcantly dif-
ferent between control and Met–Emx1 mice (Fig. 3J, D=0.2200,
pb0.001, K–S).
Total cortical volume was estimated for control (96.98±
2.59 mm3) and Met–Emx1 mice (97.30±3.48 mm3) at P30. In the
Fig. 3. Structural differences in the cerebral cortex of Met–Emx1 mice are age speciﬁc. (A–H) Representative MRI images at rostral (A–D, bregma=+1.04 mm) and caudal
(E–H, bregma=−1.66 mm) levels. Panels A, B, E, and F were obtained from P30 mice, whereas C, D, G, and H were from adult mice. (I and J) The cross-sectional area of the
cerebral cortex is plotted versus estimated bregma level for P30 (I) and adult (J) animals. The overall distributions of area are the same for control and Met–Emx1 mice at
P30 (D=0.1076, p=0.067, K–S test). Yet, the distributions are signiﬁcantly different in control and Met–Emx1 mice at adulthood (D=0.2200, pb0.001, K–S test). Arrows
denote the levels for which the rostral (gray arrows) or caudal (black arrows) images are shown. Data represent n=4 brains per genotype and age, points represent the
mean areas with the error bars signifying the SEM.
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trol) and 98.06±3.47 mm3 (Met–Emx1). There was a signiﬁcant
main effect of genotype (F(1,31)=9.290, p=0.006), but not of age
(F(1,31)=0.720, p=0.404), or hemisphere (F(1,31)=0.133, p=
0.719, three-way ANOVA) on cortical volume. There was also a signif-
icant genotype×age interaction (F(1,31)=9.671, p=0.005). The cor-
tical volume data were in agreement with the cross-sectional area
distributions.
The comparison of the cross-sectional areas showed an in increase in
theMet–Emx1mice in the frontal and parietal cortical regions. The frontal
cortical areas are associated with executive functions and emotional pro-
cessing, which are altered in ASD. Therefore, we divided the dataset into
rostral and caudal regions (at bregma=−1 mm), to speciﬁcally examine
frontal areas. At P30, rostral and caudal volumes were similar between
genotypes (control, rostral: 57.89±2.42 mm3and caudal: 39.10±
4.40 mm3; Met–Emx1, rostral: 62.88±4.77 mm3 and caudal: 34.43±
4.33 mm3). In adult Met–Emx1 mice the rostral half of cerebral cortex
appeared larger than in control mice (control: 50.41±4.03 mm3,
Met–Emx1: 63.06±4.77 mm3), while the caudal half remains similar
(control: 39.28±2.44 mm3, Met–Emx1: 34.99±4.06 mm3). At rostral
levels, there was no main effect of genotype (F(1,31)=1.219, p=
0.281) or age (F(1,31)=1.365, p=0.254), but there was a signiﬁcant
genotype×age interaction effect (F(1,31)=5.691, p=0.025), again im-
plying a combination of genotype and age leads to increased size. At
caudal levels, we found no main effects of genotype (F(1,31)=1.476,
p=0.236), age (F(1,31)=0.310, p=0.580) or genotype×age interac-
tion (F(1,31)=0.01, p=0.972).
We next sought to determine which dimensions were expanded
in the adult Met–Emx1 cortex to account for the increase in volume.
We ﬁrst measured the thickness of the cortex from pia to white matter
at the level of the barrel ﬁelds (bregma 0.34 mm to −1.96 mm)
(Paxinos and Franklin, 2001). We found no signiﬁcant difference in thethickness of the cortex at these levels in either the right (control:
1.15±0.03 mm, Met–Emx1: 1.26±0.06 mm, p=0.17, Student's t test)
or left hemispheres (control: 1.17±0.03 mm, Met–Emx1: 1.24±
0.05 mm, p=0.28, Student's t test). Next we measured the tangential
length of the cortical surface in each image, to determine the surface
area of the cortex. The total surface area of the cortex is larger in Met–
Emx1 mice (115.63±5.52 mm2) than in controls (97.18±3.47 mm2,
p=0.049, Student's t test).
Lastly, we compared the rostrocaudal distance spanned by the cere-
bral cortex. This appeared to be slightly longer in adult Met–Emx1 mice
(8.12±0.13 mm) compared to adult control (7.70±0.15 mm), and this
difference was signiﬁcant at the pb0.1 level (p=0.09, Student's t test).
No difference in rostrocaudal length was observed in P30 mice (control:
7.80±0.10 mm; Met–Emx1: 7.53±0.21 mm; p=0.32, Student's t test).
In summary, the cerebral cortex was larger in the adult Met–Emx1
mouse. This difference appears to bedue to a tangential, but not radial, ex-
pansion of the cortex. There may also be a rostrocaudal expansion of the
cortex in theMet–Emx1mouse.
Hippocampus
We measured the hippocampus, which also expresses Emx1-cre
and may be affected by loss of Met signaling (Gorski et al., 2002;
Guo et al., 2000). Lamination and subﬁelds were grossly similar in
all mice (Fig. 4A–H). Estimates of cross-sectional area showed no dif-
ference at P30 (Fig. 4I, D=0.1113, p=0.426, K–S test), but a signiﬁ-
cant difference was found in the distribution of areas between adult
control and Met–Emx1 animals (Fig. 4J, D=0.2560, p=0.001, K–S
test). This difference in the adult also translated to a difference in
the total volume of the hippocampus (control: 13.67±0.44 mm3,
Met–Emx1: 20.02±2.94 mm3, p=0.013, Bonferroni t test). We
found no main effect of either genotype (F(1,31)=2.950, p=
70 J.M. Smith et al. / NeuroImage: Clinical 1 (2012) 66–740.099), or age (F(1,31)=0.898, p=0.353), but there was a signiﬁ-
cant age×genotype interaction effect (F(1,31)=5.335, p=0.030,
ANOVA). Like the total brain and cerebral cortex analyses, theFig. 4. Loss of Met function alters hippocampal area in adult mice. Met–Emx1 and con-
trol mice have similar hippocampal cross-sectional areas at P30 (D=0.1113, p=0.426,
K–S test). The distributions of areas are signiﬁcantly different between adultMet–Emx1
and control mice (D=0.2560, p=0.001, K–S test). Representative images at rostral
(A–D, approximate bregma=−1.66) and caudal (E–H, approximate bregma=
−3.56) levels. The average cross-sectional area of the hippocampus (upper and
lower leaves) is plotted versus estimated bregma level for P30 (I) and adult (J) animals.
Arrows denote the levels for which the rostral (gray arrows) or caudal (black arrows)
images are shown. Data represent n=4 brains per genotype and age, points represent
the mean areas with the error bars signifying the SEM. Scale bar=2 mm.overall increase in hippocampal volume is due to the combination
of small effects of genotype and age.
Frontal cortical regions project to the caudal portion of the hippocam-
pus. When only the caudal portion (caudal to bregmab−2.50 mm) is
considered, there was no main effect of genotype (F(1,31)=0.561,
p=0.461) or age (F(1,31)=4.208, p=0.056), but there was a sig-
niﬁcant interaction between age and genotype (F(1,31)=12.880,
p=0.001). In control mice, the caudal portion of the hippocampus
had similar volumes at both P30 and in adulthood (p=0.38,
Bonferroni t test). But in the Met–Emx1 mice the caudal portion of
the hippocampus was signiﬁcantly larger in adult, as compared to
P30 mice (p=0.029, Bonferroni t-test). For the rostral portion
(bregma>−2.50) of the hippocampus, no signiﬁcant effect of geno-
type (F(1,31)=2.321, p=0.141), age (F(1,31)=0.758, p=0.393),
or any genotype×age interaction (F(1,31)=0.523, p=0.476) was
found. The increase in hippocampal volume therefore appears to
be restricted to the caudal hippocampus.
Striatum
The cross-sectional area of striatumofMet–Emx1 animals was found
to be similar to control at P30 (Fig. 5A, D=0.0572, p=0.984, K–S test).
However, the distributions between genotypes were different in the
adult (Fig. 5B,D=0.2157, p=0.002, K–S test). The total striatal volume
was calculated, and at P30 control mice had a volume of 16.60±
0.87 mm3 andMet–Emx1mice had a volume of 16.44±0.95 mm3. For
adult mice, the volumes were 16.96±0.57 mm3 for control mice and
21.95±2.02 mm3 for Met–Emx1 mice. We found main effects ofFig. 5. The striatum of adult Met–Emx1 mice is larger than the striatum of control mice.
Average cross-sectional area of the striatum is plotted versus estimated bregma level for
P30 (A) and adult (B) animals. Overall the distribution of area is signiﬁcantly different
in adult control and Met–Emx1 mice (D=0.2157, p=0.002, K–S test) but not between
P30 control and Met–Emx1 mice (D=0.0572, p=0.984, K–S test). Data represent n=4
brains per genotype and age, points represent the mean areas with the error bars signify-
ing the SEM.
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0.003), and a signiﬁcant genotype×age interaction (F(1,31)=8.570,
p=0.011). Striatal volumewas increased in adultMet–Emx1mice rela-
tive to adult control mice (p=0.002, Bonferroni t test) and P30 Met–
Emx1mice (p=0.003, Bonferroni t test).Thalamus
We next measured the area of the thalamus, which followed a
similar pattern to the other structures. No difference was observed
at P30 between control and Met–Emx1 mice (Fig. 6A, D=0.2002,
p=0.056, K–S test), but a signiﬁcant increase was found in the thala-
mus of adult Met–Emx1 compared to adult control mice (Fig. 6B, D=
0.3960, pb0.001, K–S test). We also calculated the volume of the thal-
amus. At P30, thalamic volume is 26.04±1.79 mm3 in control mice
and 24.86±1.48 mm3 in Met–Emx1 mice. In the adult, the volume
of the thalamus is 20.87±3.34 mm3 in control mice and 29.41±
2.09 mm3 in Met–Emx1 mice. We found no main effect of genotype
(F(1,31)=3.256, p=0.084) or age (F(1,31)=0.025, p=0.875). Yet,
the genotype×age interaction (F(1,31)=9.504, p=0.005) indicated
a difference among the dataset. Post hoc analysis revealed that the
thalamic volume of the adultMet–Emx1mice was signiﬁcantly differ-
ent from adult control mice (p=0.04, Bonferroni t test).Fig. 6. Loss of Met function alters thalamic area in adult mice. Average cross-sectional
area of the thalamus is plotted versus estimated bregma level for P30 (A) and adult
(B) animals. Overall the distribution of area is signiﬁcantly different in control and
Met–Emx1 mice in adulthood (D=0.3960, pb0.001, K–S test), but not at P30 (D=
0.2002, p=0.056, K–S test). Data represent n=4 brains per genotype and age, points
represent the mean areas with the error bars signifying the SEM.Increased thickness of the corpus callosum in adult, but not juvenile,
Met–Emx1 mice
Met has previously been implicated in neurite extension, as well as
axonal outgrowth and survival (Hamanoue et al., 1996; Maina et al.,
1997). Therefore, we measured the thickness of the CC at the midline
across the rostrocaudal extent, (bregma=+1.14 mm to −2.96 mm,
Fig. 7A–D). We found no difference between Met–Emx1 and control
mice at P30 (Fig. 7E, D=0.0723, p=0.893, K–S test). However, adult
Met–Emx1 mice have a signiﬁcantly thicker CC than control mice
(Fig. 7F, D=0.2239, p=0.001, K–S test). The difference appears
greatest towards the rostral end (bregma levels +0.1 to 1.0 mm) of
the CC (Fig. 7B). For example, at bregma +0.74 mm, the thickness of
the CC is 0.32±0.03 mm in control mice and 0.54 mm±0.08 mm in
Met–Emx1mice, and, at bregma−1.06, the CC was 0.20±0.02 mm in
control mice and 0.24±0.04 mm inMet–Emx1mice.Discussion
Our results demonstrate widespread alterations in forebrain struc-
ture in adult mice with impaired Met signaling. In the adultMet–Emx1
mice, we observed an expansion in the rostral pole, in frontal cortical
areas, and an enlargement in the caudal hippocampal areas that connect
to the frontal regions. The striatum and thalamus are expanded as well,
but more evenly across the rostrocaudal extent. None of the differences
between adult Met–Emx1 and control mice were detected in juvenile
(P30) mice. The differences observed in the adult mice support the
idea of a progressive defect.
The late postnatal nature of the enlargement of these brain areas
could be due to continued growth in the Met–Emx1 mice, or a lack of
normal pruning. The cerebral cortex and hippocampus are directly
targeted by the Emx1-Cre driver (Gorski et al., 2002), so alterations in
those structures could be due to either increased cell numbers or size
of neurons or glia (Geisert et al., 2002; Groszer et al., 2001), or increases
in the size or number of axonal or dendritic processes. The expression
pattern of the Emx1-Cre driver is largely uniform with regards to the
rostrocaudal extent of the cerebral cortex (Gorski et al., 2003), exclud-
ing the possibility that the differential effects are due to driver expres-
sion. However, Met expression has been reported to be in a low
rostral — high caudal pattern during the ﬁrst postnatal month (Judson
et al., 2009). In anothermutantmouse, the urokinase plasminogen acti-
vator receptor null, Met levelswere reported to be selectively decreased
in embryonic frontal and parietal cortical areas leading to seizures and
impaired cognition (Bae et al., 2010; Bissonette et al., 2010; Powell et
al., 2003a), providing support that loss of Met has the greatest conse-
quences in frontal regions. Frontal and limbic structures continue to de-
velop through adolescence. The enlarged frontal structures in theMet–
Emx1mice may represent the compensatory changes due to abnormal
ontogeny of the frontal pole.
Changes in the subcortical structures, the striatum and thalamus,
are perhaps best explained by an increase in white matter volume,
as reﬂected in the increased thickness of the CC. The CC is composed
primarily of contralaterally projecting axons from cortical pyramidal
neurons, both cortico-cortical and sub-cortical projections. An in-
crease in the thickness of the CC could be caused by an increase in
the number, size, or branching of axonal processes originating from
affected cells, by increased myelination, or some combination of
these factors. Both the striatum and thalamus exchange reciprocal
connections with the cortex, including the frontal cortical areas
which we found to be expanded inMet–Emx1mice. Notably, the ven-
tral hippocampus also has reciprocal connections with the frontal
cortex (Fanselow and Dong, 2010). The ventral division of the hippo-
campus is found in more caudal sections where the hippocampus
appears to be expanded in adultMet–Emx1mice, raising the possibil-
ity that the change in hippocampal size may be due to altered cortical
Fig. 7. The corpus callosum is expanded at rostral levels in adult Met–Emx1 mice.
(A–D) Representative MRI images at approximate bregma=+0.94 mm (A, B) and
−1.16 mm (C, D) levels. Dotted line demonstrates the location of the thickness measure-
ment. The average thickness of the corpus callosumat themidline is plotted versus estimated
bregma level for P30 (E) animals and adult (F)mice. Arrowsdenote the level atwhich images
are shown for rostral (black) and caudal (gray) levels. The distribution of thickness is signif-
icantly different in control and Met–Emx1 mice in adulthood (D=0.2239, p=0.001, K–S
test), but not at P30 (D=0.0723, p=0.893, K–S test). Data represent n=4 brains per geno-
type, points represent the mean areas with the error bars signifying the SEM.
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hippocampus.
Changes in both white and gray matter volume have been
detected in autistic humans. The brain is slightly smaller inindividuals with ASD at birth and undergoes a period of early
over-growth, leading to increased brain volume and head circumfer-
ence within the ﬁrst few years of life (Courchesne et al., 2011;
Redcay and Courchesne, 2005). A study of autistic patients and
controls from ages 18 months to 5 years found increased cortical
volume, gray matter volume, and white matter volume in autistic
patients, with no change in cortical thickness (Hazlett et al., 2011).
The authors therefore attributed the increase in cortical volume
to the increased surface area (volume÷thickness). After the initial
period of overgrowth, the discrepancy in growth rate diminishes,
and consequently brain volume and head circumference values
approach those of typically developing children (Redcay and
Courchesne, 2005). For example, an MRI study using individuals
with a mean age near 10 years found no difference in total brain vol-
ume, nor in gray or white matter volume in autistic patients, although
they did ﬁnd an increase in cortical thickness at this age (Hardan et
al., 2006). While most studies focus on childhood, some studies that in-
cluded older children and adults report overall increases in brain size
(Aylward et al., 1999; Piven et al., 1995), raising the possibility that
such increases could persist into adulthood in some cases. The earliest
time we examined in the mice was P30 which represents the juvenile,
closer to the 10 year old children, and this presents a limitation to our
study that we do not have an earlier structural data.
Studies focusing on white matter structures using diffusion tensor
imaging found different changes in autistic patients depending on age.
While one study on children between 1.8 and 3.3 years found increased
fractional anisotropy in the genu and splenium of the CC, as well as in
portions of the internal and external capsules and the forceps minor
(Ben Bashat et al., 2007), others in a slightly older population have
found reduced fractional anisotropy values in the CC and frontal white
matter tracts (Alexander et al., 2007; Barnea-Goraly et al., 2004).
While some reports have shown decreases in CC size (Freitag et al.,
2009; Piven et al., 1997), or no change in autistic subjects (Herbert et
al., 2004; Piven et al., 1997), others have found increased white matter
volume in autistic individuals (Freitag et al., 2009; Herbert et al., 2003;
Herbert et al., 2004). None of the studies were correlated with genetic
information, and likely represent spectrum of diverse genetic and envi-
ronmental factors leading to the ASD diagnosis.
The structural changeswe observed in the brains of adultMet–Emx1
mice may resemble some of those reported in autistic patients (Amaral
et al., 2008).While the cause in each case remains uncertain, alterations
in white matter structures seem to make a contribution in both cases.
Despite this similarity, the time course of the alterations is divergent be-
tween the two species. In addition to simple species differences, a few
factors may contribute to this divergence. Most notably, the Met–
Emx1mice undergowhat we believe to be a complete loss of the kinase
activity of Met in the cells affected by the Emx1-Cre driver, namely neu-
rons and glia in the cerebral cortex and hippocampus. Changes in the
striatumand thalamus are likely due to the cortical and hippocampal af-
ferents to these regions. By contrast, the Met polymorphism associated
with autism in humans leads to decreased transcription of MET
(Campbell et al., 2006), presumably affecting all brain areas which nor-
mally expressMET. Since Met function is not completely ablated in the
brains of humans with the polymorphism, there is the possibility that
changes in the regulation of the pathway could eventually compensate
for reduced transcription, as is found with MET in the cancer environ-
ment (Straussman et al., 2012). Similarly, the complete loss of Met in
our mouse model may lead to compensatory changes in HGF levels, or
other related pathways, that do not occur after the partial reduction in
Met signaling seen in humans. Finally, our dataset relies on separate an-
imals for each time point, and it was not a longitudinal study, and so
conclusions regarding developmental trajectory are limited by group
data. By pairing the imaging study with a single mutation and a deﬁned
phenotype, we were able to view the contribution of a single gene. The
human situation is far more complex, yet multiple allelic variants may
contribute to different stages of the ASD phenotype over the lifespan
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underpinnings of the anatomical changes seen in these mice.Acknowledgments
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